493 related articles for article (PubMed ID: 33162736)
1. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
3. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE
J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
[TBL] [Abstract][Full Text] [Related]
5. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
Front Immunol; 2022; 13():933774. PubMed ID: 35812420
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
[TBL] [Abstract][Full Text] [Related]
8. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
[TBL] [Abstract][Full Text] [Related]
9. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
[TBL] [Abstract][Full Text] [Related]
10. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
[TBL] [Abstract][Full Text] [Related]
11. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
[TBL] [Abstract][Full Text] [Related]
12. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
[TBL] [Abstract][Full Text] [Related]
13. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
[TBL] [Abstract][Full Text] [Related]
14. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
Garcia KS; Moutinho BD; de Azevedo MFC; Queiroz NSF; Milani LR; Sanches LN; Barros LL; Oba J; Carlos AS; Damião AOMC; Sipahi AM
Inflamm Intest Dis; 2020 Jun; 5(2):93-97. PubMed ID: 32984404
[TBL] [Abstract][Full Text] [Related]
15. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
[TBL] [Abstract][Full Text] [Related]
16. Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.
Richter V; Bermont A; Cohen DL; Broide E; Shirin H
Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):267-273. PubMed ID: 34191758
[TBL] [Abstract][Full Text] [Related]
17. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
[TBL] [Abstract][Full Text] [Related]
18. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234
[TBL] [Abstract][Full Text] [Related]
20. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
